David J. Nutt

Cognitive Neuroscience · 2000–2021

A researcher in the Science corpus: 16 papers; trusts 18 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

Cognitive Neuroscience — 103 citations into it; #9,373 of 10,852 by trust here, #4,352 by citations
Clinical Psychology — 80 citations into it; #2,938 of 8,024 by trust here, #1,018 by citations
Cellular and Molecular Neuroscience — 48 citations into it; #1,757 of 2,998 by trust here, #1,217 by citations
Social Psychology — 26 citations into it
Organic Chemistry — 23 citations into it; #735 of 1,495 by trust here, #1,089 by citations
Molecular Biology — 20 citations into it
Statistical and Nonlinear Physics — 16 citations into it
Toxicology — 15 citations into it; #31 of 76 by trust here, #16 by citations

Whom David J. Nutt trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts David J. Nutt overall

Papers from David J. Nutt's perspective

Ordered by how strongly the researchers David J. Nutt trusts endorse each paper. Same corpus, a different order for every researcher.

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (Frontiers in Human Neuroscience)
Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (Journal of Psychopharmacology)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. (Lancet psychiatry)
Homological scaffolds of brain functional networks (Journal of the Royal Society Interface)
Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (Journal of Psychopharmacology)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. (Journal of Clinical Psychiatry)
The Helmholtz Machine
Serotonin and brain function: a tale of two receptors (Journal of Psychopharmacology)
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (Neuropsychopharmacology)

Their papers

Homological scaffolds of brain functional networks (2014) — 682 citations
Trial of Psilocybin versus Escitalopram for Depression. (2021) — 1,023 citations
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018) — 694 citations
Serotonin and brain function: a tale of two receptors (2017) — 647 citations
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017) — 851 citations
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression (2017) — 493 citations
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. (2016) — 1,242 citations
Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016) — 759 citations
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014) — 1,084 citations
Amphetamine, past and present – a pharmacological and clinical perspective (2013) — 532 citations
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012) — 1,086 citations
Drug harms in the UK: a multicriteria decision analysis. (2010) — 1,459 citations
Sleep disorders as core symptoms of depression (2008) — 758 citations
Development of a rational scale to assess the harm of drugs of potential misuse. (2007) — 1,206 citations
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. (2006) — 1,390 citations
Associate editor: A.E. D.J.K. BalfourThe psychobiology of anxiolytic drugs: Part 1: Basic neurobiology (2000) — 134 citations